Artiva Biotherapeutics, Inc. Financial Overview
Artiva Biotherapeutics, Inc.'s market cap is currently $81.00M. The company's EPS TTM is $-0.88; its P/E ratio is -1.94; Artiva Biotherapeutics, Inc. is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
